AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2014
Jan 7, 2014
33819_dirs_2014-01-06_a3c74436-1212-477a-a8a6-7417e9abed07.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-12-20
Reporting Person: WEISSMAN IRVING (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-20 | Common Stock | A | 643 | $1.00 | Acquired | 151673 | Direct |
| 2014-01-03 | Common Stock | A | 10163 | $0.00 | Acquired | 161836 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 19012 | Indirect |
Footnotes
F1: The $1.00 per share price was the stock option exercise price for shares granted to Dr. Weissman on January 1, 2004.
F2: Includes anniversary equity grant of 10,000 restricted stock units, vesting 100% on October 1, 2014, the one year anniversary of the grant.
F3: Quarterly retainer paid to Dr. Weissman in shares of common stock as consideration for his continued service of the Company's Scientific Advisory Board.
F4: 10,508 shares held in trust as to which Dr. Weissman disclaims beneficial ownership.
More from Microbot Medical Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 10